About
Overview
Leadership
Board of directors
Register for updates
Contact
Science
Overview
IL-1β in HS
Pipeline
Overview
AVTX-009 for HS
Patients
Our commitment
Clinical trials
Resources
Access to investigational therapies
Investors
Overview
News, events, & presentations
Analyst coverage
Stock data
SEC filings
Corporate governance
IR resources
Careers
Overview
Values
Benefits
Job openings
O
ne
purpose
Press Releases
Publications
Events and Presentations
Press releases
2025
2024
2023
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Print
Contact IR
RSS
Email
